CN1305516C - Chinese medicine for treating chronic hepatitis B - Google Patents
Chinese medicine for treating chronic hepatitis B Download PDFInfo
- Publication number
- CN1305516C CN1305516C CNB200510010394XA CN200510010394A CN1305516C CN 1305516 C CN1305516 C CN 1305516C CN B200510010394X A CNB200510010394X A CN B200510010394XA CN 200510010394 A CN200510010394 A CN 200510010394A CN 1305516 C CN1305516 C CN 1305516C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- fruit
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating chronic hepatitis B, which is prepared from honeysuckle flower, forsythia fruit, linearstripe rabdosia herb, giant knotweed rhizome, abrus herb, longhairy antenoron herb, sauted atractylodes macrocephala, bupleurum root, corydalis tuber fried with vinegar, szechwan chinaberry fruit, amomun fruit, chicken's gizzard-membrane, sandenol, centipede, scorpion, notoginseng, red sage root, milkvetch root, angelica, sauted malt, sauted hawthorn fruit, medicated leaven, orange fruit, Chinese magnolivine fruit, liquorice, curcuma root, longspur epimedium and turtle shell into powder. The medicine of the present invention adopts a traditional Chinese medicine method for attacking toxin with toxin and is matched with the efficacy of promoting blood circulation, dissipating blood stasis, soothing the liver, regulating qi, relieving pain, clearing away heat, benefiting dampness, eliminating toxic substances, strengthening the spleen and stomach so as to enhance disease resistance and immunological functions of human bodies, and thereby, HbsAg+/eAb+/cAb+ can be transformed into yin in one year, and HbsAg+/eAg+/cAb+ can be transformed into yin in one half of a year to two years. The medicine has the advantages of low cost, no medicine resistance, and no toxic or side effect when the medicine is taken for a long term.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of chronic hepatitis B.
Background technology
Hepatitis B is after invading human body by hepatitis B virus, by adsorbing and penetrating, shell, duplicate, assemble and discharge, to produce a series of immunoreation, and cause hepatocellular damage.Have certain heritability and infectiousness, PD can cause canceration to the end.From for many years, doctor trained in Western medicine observes this sick therapeutic effect: the one, effect is bad, the 2nd, price is expensive especially, is adding that primary disease needs secular taking medicine, this makes a lot of patients be difficult to economically bear.Often all be to compel to stop to treat, develop into the crisis life state at last owing to economical.Because primary disease belongs to the traditional Chinese medical science " pertinacious disease " category, it is bigger to control difficulty.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of chronic hepatitis B, can reach small three positive and turn out cloudy in 1 year, great three positive year was turned out cloudy in a year and a half to two, and drug price is cheap, takes for a long time not produce drug resistance and toxic and side effects.
Medicine of the present invention is reused Flos Lonicerae, Fructus Forsythiae, Herba Rabdosiae Lophanthoidis, Rhizoma Polygoni Cuspidati, Herba Abri, Herba Lysimachiae with clearing away heat-damp and promoting diuresis, detoxifcation.Rhizoma Polygoni Cuspidati also has the jaundice eliminating effect except that heat-clearing and toxic substances removing.Rhizoma Corydalis (vinegar stir-fry), Fructus Toosendan, Fructus Amomi, Fructus Aurantii, Lignum Santali Albi, Radix Curcumae, Endothelium Corneum Gigeriae Galli, liver-smoothing, qi-regulating, help digestion expand, pain relieving.Radix Curcumae is separated the stasis of blood except that promoting blood circulation and stopping pain, circulation of qi promoting, also has the jaundice eliminating effect.Scolopendra, full scorpion obstruction removing pain relieving, treating the poisonous disease with poisonous drugs.More than all medicines the treatment hepatitis B is all played an important role and is monarch drug.Radix Notoginseng, Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, Carapax Trionycis hard masses softening and resolving, Fructus Hordei Germinatus (parched), Jiao look into, Massa Medicata Fermentata spleen invigorating stomach strengthening, strengthen the human body resistance against diseases with appetite stimulator, help monarch drug to bring into play better therapeutic effect, are ministerial drug.Epimedium, the Radix Astragali, Radix Angelicae Sinensis invigorating middle warmer gas, blood nourishing and kidney tonifying is adjuvant drug to increase body's immunity.Fructus Schisandrae Chinensis has the effect of transaminase lowering, and the Radix Bupleuri priming is gone into liver, and the Radix Glycyrrhizae mediation property of medicine is messenger drug.
Chinese medicine of the present invention is by the following raw materials in weight medicine: Flos Lonicerae 150g, Fructus Forsythiae 30g, Herba Rabdosiae Lophanthoidis 80g, Rhizoma Polygoni Cuspidati 20g, Herba Abri 50g, Herba Lysimachiae 100g, Rhizoma Atractylodis Macrocephalae 20g, Radix Bupleuri 15g, Rhizoma Corydalis (parched with vinegar) 30g, Fructus Toosendan 20g, Fructus Amomi 30g, Endothelium Corneum Gigeriae Galli 30g, Lignum Santali Albi 30g, Scolopendra 40g, Scorpio 15g, Radix Notoginseng 30g, Radix Salviae Miltiorrhizae 30g, Radix Astragali 40g, Radix Angelicae Sinensis 30g, Fructus Hordei Germinatus (parched) 30g, Jiao looks into 30g, Massa Medicata Fermentata 30g, Fructus Aurantii 20g, Fructus Schisandrae Chinensis 30g, Radix Glycyrrhizae 15g, Radix Curcumae 20g, Epimedium 30g and Carapax Trionycis 30g make powder.
Medicine of the present invention is taked the method for traditional Chinese medical science treating the poisonous disease with poisonous drugs, cooperates blood circulation promoting and blood stasis dispelling, liver-smoothing, qi-regulating, pain relieving, clearing away heat-damp and promoting diuresis detoxifcation, spleen invigorating stomach strengthening and strengthen human body resistance against diseases and immunologic function.The liver and the kidney have a common source one says that with the passing of time hepatopathy accumulates the saying of kidney according to the traditional Chinese medical science, mends its kidney.We have received hundred-percent effect really through clinical use for many years.
The specific embodiment
Below by clinical observation test, further set forth the beneficial effect of Chinese medicine of the present invention
1, physical data
Patient's 138 examples are accepted in outpatient service for medical treatment, male 70 examples, and women 68 examples, the age is in 8-60 year.
2, diagnostic criteria
Chronic hepatitis B, according to the liver function damaged condition be divided into gently, in, severe.Slightly: the course of disease surpasses half a year, and disease is lighter, and symptom of digestive tract is arranged, and no jaundice or jaundice are slight, and liver silght enlargement, spleen are generally untouchable.Moderate: the course of disease surpasses half a year, symptom is heavier, except that the digestion symptom, the outer many organ injuries symptom of liver also can appear, as arthritis, nephritis, colitis etc., wherein see the many enlargements of liver spleen with arthritis, chronic nephritis more, often have tenderness and quality to change, part patient has symptoms such as spider angioma, liver palm.Severe: medical history is more than half a year, and symptom of digestive tract is more obvious, and as abdomen battle, distension, hepatalgia is accompanied obvious jaundice, and liver function is damaged more serious.
3, Therapeutic Method:
Each clothes 5 grams of Chinese medicine of the present invention, 3 times on the one, one after each meal, 2 months is a course of treatment, takes continuously, till turning out cloudy.
4, efficacy assessment standard
Recovery from illness: through clothes medicine 1-2 of the present invention course of treatment, abdominal distention, stomachache, hepatalgia, symptoms such as hepatic region enlargement all take an evident turn for the better, and along with taking medicine of longer time, produce positive trend of turning out cloudy gradually.Great three positive changeed small three positive average approximately 8-12 month, and small three positive was turned out cloudy average approximately 8-10 month.Produce effects: after course of treatment, what at first occur is that symptom of digestive tract makes moderate progress through clothes medicine of the present invention, and appetite sees and increase that the uncomfortable liver area sx is taken medicine along with secular, though symptom takes a turn for the better to some extent, does not reach optimum efficiency.Invalid: as all not have the improvement phenomenon by a series of symptoms that hepatitis B showed.
5, result
Cure 126 examples, produce effects 12 examples, invalid 0 example, cure rate: 91.3%, total effective rate 100%.
Claims (1)
1, a kind of Chinese medicine for the treatment of chronic hepatitis B, it is characterized in that by the following raw materials in weight medicine: Flos Lonicerae 150g, Fructus Forsythiae 30g, Herba Rabdosiae Lophanthoidis 80g, Rhizoma Polygoni Cuspidati 20g, Herba Abri 50g, Herba Lysimachiae 100g, Rhizoma Atractylodis Macrocephalae 20g, Radix Bupleuri 15g, Rhizoma Corydalis (parched with vinegar) 30g, Fructus Toosendan 20g, Fructus Amomi 30g, Endothelium Corneum Gigeriae Galli 30g, Lignum Santali Albi 30g, Scolopendra 40g, Scorpio 15g, Radix Notoginseng 30g, Radix Salviae Miltiorrhizae 30g, Radix Astragali 40g, Radix Angelicae Sinensis 30g, Fructus Hordei Germinatus (parched) 30g, Jiao look into 30g, Massa Medicata Fermentata 30g, Fructus Aurantii 20g, Fructus Schisandrae Chinensis 30g, Radix Glycyrrhizae 15g, Radix Curcumae 20g, Epimedium 30g and Carapax Trionycis 30g and make powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510010394XA CN1305516C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating chronic hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510010394XA CN1305516C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating chronic hepatitis B |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772253A CN1772253A (en) | 2006-05-17 |
CN1305516C true CN1305516C (en) | 2007-03-21 |
Family
ID=36759505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510010394XA Expired - Fee Related CN1305516C (en) | 2005-09-27 | 2005-09-27 | Chinese medicine for treating chronic hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1305516C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100457172C (en) * | 2006-11-10 | 2009-02-04 | 韩贤哲 | A Chinese traditional medicine for treatment of hepatitis and its preparation methods |
CN101444578B (en) * | 2008-12-15 | 2011-01-26 | 李凤霞 | A traditional Chinese medicine for the treatment of hepatitis |
CN102614428B (en) * | 2012-05-04 | 2013-08-07 | 南京中医药大学 | Chinese herbal powder for treating hepatic fibrosis and preparation method thereof |
CN105213597A (en) * | 2015-10-08 | 2016-01-06 | 广西德坤瑶药业有限公司 | Yao medicinal composition of a kind of Hepatoma therapy, gastric cancer, intestinal cancer and preparation method thereof |
CN106177474A (en) * | 2016-09-06 | 2016-12-07 | 福建虎伯寮药业有限责任公司 | A kind of roxburgh anoectochilus terminal bud buccal tablet with treatment chronic hepatitis effect |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083712A (en) * | 1993-04-11 | 1994-03-16 | 孟福厚 | A kind of medicine of preventing and treating hepatitis B |
CN1093922A (en) * | 1993-09-26 | 1994-10-26 | 张勤勇 | A kind of medicine for the treatment of hepatitis B |
CN1136539A (en) * | 1995-01-09 | 1996-11-27 | 三菱化学株式会社 | Method for producing coal ash particle |
CN1223133A (en) * | 1998-11-24 | 1999-07-21 | 雷玉宏 | Medicine for curing hepatitis B |
CN1270825A (en) * | 2000-03-20 | 2000-10-25 | 黄绍华 | Chinese medicine for treading hepatitis A and B and its recipe |
CN1579427A (en) * | 2003-08-14 | 2005-02-16 | 李锡宽 | Traditional Chinese medicine for treating hepatitis B and its preparation method |
-
2005
- 2005-09-27 CN CNB200510010394XA patent/CN1305516C/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083712A (en) * | 1993-04-11 | 1994-03-16 | 孟福厚 | A kind of medicine of preventing and treating hepatitis B |
CN1093922A (en) * | 1993-09-26 | 1994-10-26 | 张勤勇 | A kind of medicine for the treatment of hepatitis B |
CN1136539A (en) * | 1995-01-09 | 1996-11-27 | 三菱化学株式会社 | Method for producing coal ash particle |
CN1223133A (en) * | 1998-11-24 | 1999-07-21 | 雷玉宏 | Medicine for curing hepatitis B |
CN1270825A (en) * | 2000-03-20 | 2000-10-25 | 黄绍华 | Chinese medicine for treading hepatitis A and B and its recipe |
CN1579427A (en) * | 2003-08-14 | 2005-02-16 | 李锡宽 | Traditional Chinese medicine for treating hepatitis B and its preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN1772253A (en) | 2006-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1317026C (en) | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method | |
CN101129595A (en) | Traditional Chinese medicine for treating lumbago due to kidney deficiency | |
CN1305516C (en) | Chinese medicine for treating chronic hepatitis B | |
CN102512630A (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN101658657B (en) | Drug for treating chronic cholecystitis | |
CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
CN101564529A (en) | Five-poisonous-creature Keyin capsule of traditional Chinese medicine for treating psoriasis | |
CN100998722A (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
CN102283956A (en) | Orally administered drug for treating chronic hepatitis | |
CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
CN1879853A (en) | A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same | |
CN102078517A (en) | Traditional Chinese medicine for treating tumor | |
CN102397431B (en) | Appendicitis treating oral liquid | |
CN108853221A (en) | A kind of drug and preparation method thereof for preventing and treating newcastle disease | |
CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
CN102641479B (en) | Drug composite for treating hepatitis c | |
CN101455814B (en) | Traditional Chinese medicine for treating lumbago and scelalgia | |
CN102949684B (en) | Medicine formula for treating rheumatoid arthritis | |
CN106692588A (en) | Traditional Chinese medicine formula for treating liver cirrhosis | |
CN101176768A (en) | Epityphlon health | |
CN101036742A (en) | Medicine for treating prostatic disease | |
CN101028401A (en) | Oral Chinese medicine for treating difficult menstruation | |
CN105106385A (en) | Traditional Chinese medicine decoction for treating viral hepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20110927 |